Minimally invasive techniques by the numbers — a allergy and immunology snapshot

Emerging evidence indicates that digital tooling shortens time-to-decision considerably, pending validation in prospective studies. In multidisciplinary settings, cost considerations continue to shape adoption in smaller units, pending validation in prospective studies. Across multiple cohorts, variability between operators remains a key limitation, pending validation in prospective studies. Longitudinal data show that integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary.

Across multiple cohorts, cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. Emerging evidence indicates that standardized reporting improves comparability between centers, with meaningful differences between subgroups.